Please login to the form below

Not currently logged in

safety review

This page shows the latest safety review news and features for those working in and with pharma, biotech and healthcare.

US government shutdown leaves FDA running on empty

US government shutdown leaves FDA running on empty

One action we’ll be taking is to re-allocate user fee money from certain pre-market drug review work to post-market drug safety surveillance,” he said. ... But the functions that can most directly impact consumer safety will continue, to the best of

Latest news

More from news
Approximately 2 fully matching, plus 74 partially matching documents found.

Latest Intelligence

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    As AZ can attest, with Forxiga initially being turned down by the FDA and Onglyza under safety review to investigate any link to heart failure, the regulatory environment has been a ... tough one for oral diabetes drugs in recent years, with the FDA

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...